DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC.

Thoracic Cancer
Hiroyuki OgawaMasahiro Yoshimura

Abstract

The mammalian Notch family ligands delta-like 3 (DLL3) is reported to be a potential therapeutic target for large cell neuroendocrine carcinomas (LCNEC). The effect of DLL3 expression on LCNEC prognosis has not yet been elucidated. We reviewed the medical records of 70 LCNEC patients undergoing surgical resection between 2001 and 2015 using a prospectively maintained database. We performed immunohistochemistry for DLL3 and investigated the correlation between the sensitivity of LCNEC to platinum-based adjuvant chemotherapy. DLL3 expression was positive in 26 (37.1%) LCNEC patients. A total of 23 patients (32.9%) received platinum-based adjuvant chemotherapy. Among patients with DLL3 expression-positive tumors, no difference was found in the five-year overall survival (OS) or recurrence-free survival (RFS) between patients with and without adjuvant chemotherapy (surgery + chemotherapy vs. surgery alone, five-year OS: 58.3% vs. 35.7% P = 0.36, five-year RFS: 41.7% vs. 35.7% P = 0.74). In contrast, among patients with DLL3-negative tumors, significantly greater five-year OS and RFS rates were observed for patients with adjuvant chemotherapy than for those without it (surgery + chemotherapy vs. surgery alone: five-year OS: 90.0% vs...Continue Reading

References

Apr 15, 1990·Cancer·C ConillM Salamero
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giulio RossiElisabeth Brambilla
Dec 31, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hisao AsamuraKanji Nagai
May 16, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giulia VeronesiLorenzo Spaggiari
Jul 25, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kenzo HiroshimaYukio Nakatani
Oct 26, 2006·The Annals of Thoracic Surgery·Akira IyodaTakehiko Fujisawa
Aug 1, 2007·The Journal of Cell Biology·Insa GeffersAchim Gossler
Sep 13, 2007·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Kathleen M LoomesKenro Kusumi
Jul 9, 2009·Chest·Frank C DetterbeckLynn T Tanoue
Jul 22, 2009·The Journal of Thoracic and Cardiovascular Surgery·Akira IyodaIchiro Yoshino
May 24, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nader AbedallaaBenjamin Besse
Apr 11, 2014·General Thoracic and Cardiovascular Surgery·Akira IyodaYoshinobu Hata
Jun 4, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Morena FasanoFloriana Morgillo
Jul 15, 2015·Nature·Julie GeorgeRoman K Thomas
May 6, 2016·Frontiers in Oncology·Judy S CrabtreeLucio Miele
Apr 21, 2019·The Annals of Thoracic Surgery·Vignesh RamanDavid H Harpole
Aug 27, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hao XieAnja C Roden
Sep 12, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel MorgenszternDavid P Carbone

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
xenografts

Software Mentioned

JMP

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.